The CHILD Trial: Hypoplastic Left Heart Syndrome Study.

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 16, 2019

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions
Hypoplastic Left Heart Syndrome
Interventions
BIOLOGICAL

c-kit+ cells

The autologous c-kit+ cells will be harvested from participant's right atrial tissue obtained from participant's SOC Norwood Operation. The harvested c-kit+ cells containing up to a total of 12,500 cells/kg will be delivered through 6-10 intramyocardial injections of approximately 100uL per injection for a total volume of approximately 0.6 mL.

Trial Locations (3)

21201

University of Maryland - Division of Cardiac Surgery, Baltimore

30322

Emory University Children's Healthcare of Atlanta - Egleston Campus, Atlanta

48109

Michigan Medicine Congenital Heart Center/C.S. Mott Children's Hospital, Ann Arbor

All Listed Sponsors
lead

Joshua M Hare

OTHER

NCT03406884 - The CHILD Trial: Hypoplastic Left Heart Syndrome Study. | Biotech Hunter | Biotech Hunter